MedTrace Logo

Coagulation Activation in Patients With Pemphigus

NCT06285435 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2024-02-29

No results posted yet for this study

Summary

Aim of work:

1. To evaluate the plasma markers of coagulation activation: prothrombin F1+2 and d-dimer levels in pemphigus patients with active disease and compare them with age and sex-matched controls.
2. To evaluate the correlation of these markers with disease severity score by using Pemphigus Disease Area Index (PDAI) and with disease activity by measurement of anti-desmoglein 1 and 3 antibody titers.

Conditions

  • Pemphigus

Interventions

DIAGNOSTIC_TEST

prothrombin fragment 1+2

Blood sample

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-10-31
Completion
2026-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06285435 on ClinicalTrials.gov